BEUDAMED
    4,141 results · 37ms · Sources: EU EUDAMED, US FDA

    Nettle

    Device
    EU MDR · Eu Md Class 2a ·Samphire Neuroscience Ltd·On the market·15 countries

    Monitor, U.V., Glc

    FDA classification
    FDA Class 1 ·Monitor, U.V., Glc

    Coating, Liquid, Glc

    FDA classification
    FDA Class 1 ·Coating, Liquid, Glc

    Column Supports, Glc

    FDA classification
    FDA Class 1 ·Column Supports, Glc

    PHC Europe B.V.

    Authorized representative
    🇳🇱 Netherlands·3 Manufacturers·12 Devices

    Titrimetric Permanganate And Bromophenol Blue, Calcium

    FDA classification
    FDA Class 2 ·Titrimetric Permanganate And Bromophenol Blue, Calcium

    System, Test, Systemic Lupus Erythematosus

    FDA classification
    FDA Class 2 ·System, Test, Systemic Lupus Erythematosus

    PATHFAST SAMPLE DILUENT 1

    Basic UDI-DI
    EU IVDR · Eu Ivd Class A ·PHC Corporation·1 device

    PATHFAST SAMPLE DILUENT 2

    Basic UDI-DI
    EU IVDR · Eu Ivd Class A ·PHC Corporation·1 device

    PATHFAST SAMPLE DILUENT 3

    Basic UDI-DI
    EU IVDR · Eu Ivd Class A ·PHC Corporation·1 device

    Incubator

    Basic UDI-DI
    EU MDR · Eu Md Class 1 ·PHC Corporation·1 device

    PATHFAST

    Basic UDI-DI
    EU IVDR · Eu Ivd Class A ·PHC Corporation·3 devices

    Injection Device

    Basic UDI-DI
    EU MDR · Eu Md Class 2a ·PHC Corporation In Vitro Diagnostics Division·5 devices

    System, Test, Her-2/Neu, Ihc

    FDA classification
    FDA Class 3 ·System, Test, Her-2/Neu, Ihc

    Methicillin Resistant Staphylococcus Aureus/Methicillin Susceptible Staphylococcus Aureus Blood Culture Test Bt

    FDA classification
    FDA Class 1 ·Methicillin Resistant Staphylococcus Aureus/Methicillin Susceptible Staphylococcus Aureus Blood Culture Test Bt

    Cooling Gel

    Basic UDI-DI
    EU MDR · Eu Md Class 1 ·Geocos B.V.·1 device

    Cervical Intraepithelial Neoplasia (Cin) Test System

    FDA classification
    FDA Class 2 ·Cervical Intraepithelial Neoplasia (Cin) Test System

    System, Test, (Ihc), Tumor Marker, Monitoring, Bladder Cancer

    FDA classification
    FDA Class 2 ·System, Test, (Ihc), Tumor Marker, Monitoring, Bladder Cancer

    V1 091763 0015

    Certificate
    IVDD Annex IV (excluding sections 4, 6)·GC MEDIS Corp.·TÜV SÜD Product Service GmbH·18 Basic UDI-DIs

    V74 091763 0019

    Certificate
    IVDD Annex IV (excluding sections 4, 6)·GC MEDIS Corp.·TÜV SÜD Product Service GmbH·1 Basic UDI-DI